Tampa, Florida 2021-10-27 11:39:05 –
London — Pharmaceutical company Merck has agreed to allow other pharmaceutical companies to treat COVID-19. This is the first tablet that has been shown to be effective against this disease.
The move aims to make medicine accessible to millions of people in poor countries.
The UN-backed drug patent pool said in a statement Wednesday that it had signed a voluntary licensing agreement with Merck and its partners Ridgeback Biotherapy and Molnupiravir.
The agreement will allow the Medicines Patent Pool to grant additional licenses to qualified companies wishing to manufacture pharmaceuticals.
Neither pharmaceutical company will receive royalties under agreement as long as the World Health Organization considers COVID-19 to be a global emergency.
Molnupiravir is a potent ribonucleoside analog that inhibits the replication of the COVID-19 virus.
Early this month, Merck, trials show reduced hospitalization and mortality in laboratory-confirmed mild to moderate COVID-19 adult patients with at least one risk factor associated with poor disease outcome it was done.
After announcing the results of the clinical trial, White House medical adviser Dr. Anthony Fauci said the data on the drug are promising.
“It’s 50% less important. Eight people died in the placebo group and no deaths in the treatment group. This is also very important and very good news,” Fauci said.
The federal government has already purchased 1.7 million doses of Merck’s medicine, and you can buy more.
“If approved, the right way to think about this is a potential additional tool in the toolbox to protect people from the worst consequences of COVID,” said Jeff Seients, coordinator of the White House’s COVID-19 response team. I think it is. ” “But I think it’s very important to remember that vaccination remains the best tool for COVID-19. In the first place, you can prevent getting infected with COVID. You want to prevent infections. It’s not just about waiting for treatment once. It happens. “
Merck agrees to let other drug makers make its COVID pill Source link Merck agrees to let other drug makers make its COVID pill